EUVIMEDEUVIMED entdecken
Crossref

Can Histopathological Features Predict Outcomes in Grade 2 Meningiomas?

Madeline W. Elder, Alexander D. Rebchuk, Kira Tosefsky, Celine Hounjet, Karina Chornenka, Stephen Yip, Serge Makarenko

Journal of Neurological Surgery Part B: Skull Base · 01.02.2024 · 85 (S 01 S 01) · S1-S398

DOI: 10.1055/s-0044-1779965 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.02.2024. Verfasst von Madeline W. Elder und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The WHO Classification of CNS tumors grades meningiomas based on the presence of atypical (grade 2) or anaplastic (grade 3) histological features, or their absence (grade 1). Increasing grade is associated with worse recurrence and survival rates. Grade 2 tumors form a heterogeneous class both in their histological features and prognoses, and it remains unclear whether specific histological features can be used to predict outcomes within this class.

Objective

The goal of this study was to determine the prognostic value of atypical histological features currently used for classification of grade 2 meningiomas.

Methods

We used multivariate logistic regression and Cox regression to model the effects of each of seven histological features (proliferative index, brain invasion, small cell change, hypercellularity, sheeting, spontaneous necrosis and prominent nucleoli) on recurrence and survival in a large cohort of patients with grade 2 meningiomas, while controlling for the extent of resection, NF2 status, and exposure to adjuvant radiotherapy.

Results

We included 189 patients with mean age 57.4 ± 14.6 years, 64% of whom were female. The median follow-up time was 64 (IQR: 20–96) months. There was no correlation between the presence of any atypical histological feature and recurrence or survival at 1 or 5 years, except for the relationship between proliferative index and survival at 1 year (OR = 0.044, 95% CI [0.0016, 0.48], p = 0.021). However, proliferative index was not significantly correlated with recurrence at 1 year (OR = 3.32, 95% CI [0.58–6.3], p = 0.26) or 5 years (OR = 1.98, 95% CI [0.69, 6.22], p = 0.21), or survival at 5 years (OR = 0.43, 95% CI [0.12, 1.66], p = 0.2).

Discussion

In a large retrospective cohort of patients with grade 2 meningiomas, we failed to find any relationship between specific histological features and recurrence or survival outcomes. Although histology has allowed us to broadly stratify meningiomas with the WHO grading system, this suggests it should not be used for prognostication of grade 2 tumors and highlights the importance of pursuing other approaches to prognostication. Publication History Article published online: 05 February 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Elder, M. W., Rebchuk, A. D., Tosefsky, K., Hounjet, C., Chornenka, K., Yip, S., & Makarenko, S. (2024). Can Histopathological Features Predict Outcomes in Grade 2 Meningiomas?. Journal of Neurological Surgery Part B: Skull Base, 85(S 01 S 01), S1-S398. https://doi.org/10.1055/s-0044-1779965

Vancouver

Elder MW, Rebchuk AD, Tosefsky K, Hounjet C, Chornenka K, Yip S, et al. Can Histopathological Features Predict Outcomes in Grade 2 Meningiomas?. Journal of Neurological Surgery Part B: Skull Base. 2024;85(S 01 S 01):S1-S398. doi:10.1055/s-0044-1779965

BibTeX
@article{Elder2024,
  author = {Elder, Madeline W. and Rebchuk, Alexander D. and Tosefsky, Kira and Hounjet, Celine and Chornenka, Karina and Yip, Stephen and Makarenko, Serge},
  title = {Can Histopathological Features Predict Outcomes in Grade 2 Meningiomas?},
  journal = {Journal of Neurological Surgery Part B: Skull Base},
  year = {2024},
  volume = {85},
  number = {S 01 S 01},
  pages = {S1--S398},
  doi = {10.1055/s-0044-1779965}
}
Kostenlos starten →